首页> 外文期刊>ACS catalysis >Asymmetric Synthesis of Dihydropinidine Enabled by Concurrent Multienzyme Catalysis and a Biocatalytic Alternative to Krapcho Dealkoxycarbonylation
【24h】

Asymmetric Synthesis of Dihydropinidine Enabled by Concurrent Multienzyme Catalysis and a Biocatalytic Alternative to Krapcho Dealkoxycarbonylation

机译:通过并发偏见催化和生物催化替代的kRapcho Dealkoxycarencation的不对称合成二氢丙酮的不对称合成

获取原文
获取原文并翻译 | 示例
           

摘要

Dihydropinidine is a piperidine alkaloid found in spruce needles that has shown promising antifeedant activity against the large pine weevil, a widespread and economically relevant pest of coniferous tree plantations. Chemo-enzymatic approaches have previously been shown to enable a step economic access to both enantiomers of this alkaloid, but the scalability of these syntheses is limited. Herein, we report a chemo-enzymatic route to dihydropinidine that is dominated by biocatalytic steps and affords the target alkaloid in excellent stereoisomeric purity (>99% ee and de) and high yield (57% overall) on multigram scale. Our synthesis makes use of a solvent-free, Lewis acid-catalyzed Michael addition and a biocatalytic alternative to Krapcho dealkoxycarbonylation, achieved by pig liver esterase (PLE)-catalyzed ester hydrolysis and acidification, and specifically developed for this purpose, to access a key intermediate, nonane-2,6-dione. This diketone is then converted into dihydropinidine by a concurrent one-pot (cascade) biotransformation catalyzed by a transaminase, an imine reductase, and an alcohol dehydrogenase. High yields and excellent regio- and stereoselectivities of the individual transformations render chromatographic purification of intermediates unnecessary and make it possible to carry out the entire sequence with a final hydrochloride precipitation of the target alkaloid as the sole purification step.
机译:二氢丙酮是一种哌啶生物碱,其在云杉针中发现,针对大松树象鼻虫,这是针叶树种植园的广泛和经济相关害虫的有前途的抗细胺活性。先前已经显示了化学酶方法,使得能够对这种生物碱的映体进行阶梯经济进入,但这些合成的可扩展性是有限的。在此,我们报告了通过生物催化步骤支配的化学酶促途径,其主要是生物催化步骤,并在多粒子量表上提供优异的立体异构纯度(> 99%和DE)和高产率(57%)的靶生物碱。我们的合成利用无溶剂,Lewis酸催化的迈克尔加法和Krapcho Dealkoxycarbonation的生物催化替代品,通过猪肝酯酶(PLE) - 催化酯水解和酸化,并专门为此目的开发,用于访问钥匙中间体,壬烷-2,6-二酮。然后通过通过转氨酶,亚胺还原酶和醇脱氢酶催化的同时的单罐(级联)生物转化转化为二氢丙烯啶转化为二氢丙基。单个转化的高产率和优异的序列和立体选择性,不必要地使中间体的色谱纯化,并使得可以通过唯一纯化步骤进行靶生物碱的最终盐酸盐沉淀的整个序列。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号